| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d037bc74e34c7d73dd883f208aef0518 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate |
1988-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3752b723a844de17a1651d41f3a03c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b44a115a77fd2f545f7926036475ed35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_737e76d61230f9b0addf7896575ef55e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ef889af8b6d6d8bbb209a8c6b6a090a |
| publicationDate |
1992-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PT-88436-B |
| titleOfInvention |
PROCESS FOR THE PREPARATION OF MODIFIED PLASMINOGENIC ACTIVATORS |
| abstract |
This invention relates to a method for producing Growth Factor-like domain (GFD) altered, single chain urokinase (scuPA)-derived, glycosylated plasminogen activators (hereinbelow referred to also as GASGAs). The compounds of the invention are preferably prepared by genetic engineering of the uPA coding DNA and possess improved pharmacological properties. |
| priorityDate |
1987-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |